200 related articles for article (PubMed ID: 25078098)
1. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
Cangelosi D; Muselli M; Parodi S; Blengio F; Becherini P; Versteeg R; Conte M; Varesio L
BMC Bioinformatics; 2014; 15 Suppl 5(Suppl 5):S4. PubMed ID: 25078098
[TBL] [Abstract][Full Text] [Related]
2. Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.
Cangelosi D; Blengio F; Versteeg R; Eggert A; Garaventa A; Gambini C; Conte M; Eva A; Muselli M; Varesio L
BMC Bioinformatics; 2013; 14 Suppl 7(Suppl 7):S12. PubMed ID: 23815266
[TBL] [Abstract][Full Text] [Related]
3. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
4. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
[TBL] [Abstract][Full Text] [Related]
5. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Versteeg R; Caron HN; Molenaar JJ; Ora I; Eva A; Puppo M; Varesio L
Mol Cancer; 2010 Jul; 9():185. PubMed ID: 20624283
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
7. Fuzzy support vector machine: an efficient rule-based classification technique for microarrays.
Hajiloo M; Rabiee HR; Anooshahpour M
BMC Bioinformatics; 2013; 14 Suppl 13(Suppl 13):S4. PubMed ID: 24266942
[TBL] [Abstract][Full Text] [Related]
8. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
[TBL] [Abstract][Full Text] [Related]
9. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
De Preter K; Mestdagh P; Vermeulen J; Zeka F; Naranjo A; Bray I; Castel V; Chen C; Drozynska E; Eggert A; Hogarty MD; Izycka-Swieszewska E; London WB; Noguera R; Piqueras M; Bryan K; Schowe B; van Sluis P; Molenaar JJ; Schramm A; Schulte JH; Stallings RL; Versteeg R; Laureys G; Van Roy N; Speleman F; Vandesompele J
Clin Cancer Res; 2011 Dec; 17(24):7684-92. PubMed ID: 22031095
[TBL] [Abstract][Full Text] [Related]
10. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue.
Chen Z; Li J; Wei L
Artif Intell Med; 2007 Oct; 41(2):161-75. PubMed ID: 17851055
[TBL] [Abstract][Full Text] [Related]
11. Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
Stricker TP; Morales La Madrid A; Chlenski A; Guerrero L; Salwen HR; Gosiengfiao Y; Perlman EJ; Furman W; Bahrami A; Shohet JM; Zage PE; Hicks MJ; Shimada H; Suganuma R; Park JR; So S; London WB; Pytel P; Maclean KH; Cohn SL
Mol Oncol; 2014 May; 8(3):669-78. PubMed ID: 24560446
[TBL] [Abstract][Full Text] [Related]
12. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L
BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978
[TBL] [Abstract][Full Text] [Related]
13. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
14. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
15. Analyzing gene expression data for pediatric and adult cancer diagnosis using logic learning machine and standard supervised methods.
Verda D; Parodi S; Ferrari E; Muselli M
BMC Bioinformatics; 2019 Nov; 20(Suppl 9):390. PubMed ID: 31757200
[TBL] [Abstract][Full Text] [Related]
16. Simple decision rules for classifying human cancers from gene expression profiles.
Tan AC; Naiman DQ; Xu L; Winslow RL; Geman D
Bioinformatics; 2005 Oct; 21(20):3896-904. PubMed ID: 16105897
[TBL] [Abstract][Full Text] [Related]
17. Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment.
Rosswog C; Schmidt R; Oberthuer A; Juraeva D; Brors B; Engesser A; Kahlert Y; Volland R; Bartenhagen C; Simon T; Berthold F; Hero B; Faldum A; Fischer M
Neoplasia; 2017 Dec; 19(12):982-990. PubMed ID: 29091799
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of set-level techniques in predictive classification of gene expression samples.
Holec M; Kléma J; Zelezný F; Tolar J
BMC Bioinformatics; 2012 Jun; 13 Suppl 10(Suppl 10):S15. PubMed ID: 22759420
[TBL] [Abstract][Full Text] [Related]
19. Integration of multiple types of genetic markers for neuroblastoma may contribute to improved prediction of the overall survival.
Polewko-Klim A; Lesiński W; Mnich K; Piliszek R; Rudnicki WR
Biol Direct; 2018 Sep; 13(1):17. PubMed ID: 30236139
[TBL] [Abstract][Full Text] [Related]
20. Integration of molecular features with clinical information for predicting outcomes for neuroblastoma patients.
Han Y; Ye X; Wang C; Liu Y; Zhang S; Feng W; Huang K; Zhang J
Biol Direct; 2019 Aug; 14(1):16. PubMed ID: 31443736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
